Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-07-31

Clinical Trial Update: Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing laser therapy vs bevacizumab injection for diabetic macular edema was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: WITHDRAWN